Oaktree Acquisition Corp. III Life Sciences - Equity Warrant

SecurityOACCW / Oaktree Acquisition Corp. III Life Sciences - Equity Warrant
InstitutionDecagon Asset Management LLP
Latest Disclosed Ownership162,702 shares
Latest Disclosed Value $ 122,026
Decagon Asset Management LLP reports 10.30% increase in ownership of OACCW / Oaktree Acquisition Corp. III Life Sciences - Equity Warrant

On May 15, 2026 - Decagon Asset Management LLP filed a 13F-HR form disclosing ownership of 162,702 shares of Oaktree Acquisition Corp. III Life Sciences - Equity Warrant (US:OACCW) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 147,502 shares of Oaktree Acquisition Corp. III Life Sciences - Equity Warrant. This represents a change in shares of 10.30% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OAKTREE ACQUISITION CORP III *W EXP 09/01/203 G6717R112 162,702 15,200 10.30 122 17.31 0.0316
2026-02-17 2025-12-31 13F OAKTREE ACQUISITION CORP III *W EXP 09/01/203 G6717R112 147,502 -45,122 -23.42 105 -27.78 0.0403
2025-11-14 2025-09-30 13F OAKTREE ACQUISITION CORP III *W EXP 09/01/203 G6717R112 192,624 7,877 4.26 144 -10.56 0.0729
2025-08-14 2025-06-30 13F OAKTREE ACQUISITION CORP III *W EXP 09/01/203 G6717R112 184,747 3,305 1.82 162 18.38 0.1054
2025-05-15 2025-03-31 13F OAKTREE ACQUISITION CORP III *W EXP 09/01/203 G6717R112 181,442 -544 -0.30 136 -14.47 0.0977
2025-02-14 2024-12-31 13F/A-1 OAKTREE ACQUISITION CORP III *W EXP 09/01/203 G6717R112 181,986 181,986 160 0.0729
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.